Real Estate - Aroundtown shows successful result of GBP & USD Hybrid exchange and tender. Public Storage 1Q24: Slightly softer but no real concerns for credit investors. WP Carey 1Q24: Slight miss, but strong cash balance and liquidity
TFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public Offering FORT WORTH, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the closing of its previously announced public offering of an aggregate of 1,665,219 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up ...
BBSI Reports Strong First Quarter 2024 Financial Results - Revenues of $265.8 Million With Gross Billings up 7% - VANCOUVER, Wash., May 01, 2024 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (“BBSI” or the “Company”) (NASDAQ: BBSI), a leading provider of business management solutions, reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Summary vs. Year-Ago Quarter Revenues up 4% to $265.8 million.Gross billings up 7% to $1.91 billion.Average worksite employees (“WSEs”) up 3%.Net loss of $0.1 million, or $(0.02) per diluted share, co...
VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL), (“Viking”), and (“ArrowMark”) announced today that they have entered into a collaboration to advance new antibody drug programs with an aim to launch multiple asset-based companies. The first two programs will be in the area of immunology. The collaboration brings together Viking and ArrowMark’s expertise in early-stage investing and company creation with AbCellera’s for discovering and developing antibody medicines. Under the collaboration, ArrowMark and Viking will lead the initial process of program selection, followed by ...
TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the pricing of a public offering of an aggregate of 1,665,219 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 1,665,219 shares of common st...
TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting Data Now Available on Company Website Following 8-K Filing Data Demonstrate that Treatment with TFF TAC Prevents Lung Transplant Rejection at Only One-sixth of the Dose of Oral Tacrolimus and at Two-thirds of the Oral Tacrolimus Systemic Trough Exposures Gene Expression Biomarker Data Demonstrate that Treatment with TFF TAC Leads to Normalization of Expression of Rejection-Related Genes FORT WORTH, Texas...
Alto Ingredients, Inc. to Release First Quarter 2024 Financial Results on May 6, 2024 PEKIN, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel and essential ingredients and the largest producer of specialty alcohols in the United States, announced it will release its first quarter 2024 financial results after the close of market on Monday, May 6, 2024. Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time and will deliver prepared remarks via webcast followed by a question-and-a...
Marathon Digital Holdings Increases 2024 Hash Rate Target to 50 Exahash New 50 EH/s Target Represents Approximately 100% Growth in Hash Rate during Fiscal Year 2024 Fort Lauderdale, FL, April 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:) ("Marathon" or "Company"), one of the world’s largest publicly traded Bitcoin miners and a leader in supporting and securing the Bitcoin ecosystem, today announced that the Company is increasing its hash rate target for fiscal year 2024 from 35-37 EH/s to 50 EH/s. Marathon began 2024 with approximately 24.7 EH/s energized and had been planning to grow its...
BRT Apartments Corp. Announces Filing Date for First Quarter 2024 Earnings Results GREAT NECK, N. Y., April 25, 2024 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE:BRT), a real estate investment trust that owns, operates, and, to a lesser extent, holds interests in joint ventures that own multi-family properties, today announced it intends to file its Form 10-Q for the quarter ended March 31, 2024 with the Securities and Exchange Commission on or about May 9, 2024. The Company does not intend to conduct an earnings call to discuss the results. BRT is a real estate investment trust that ...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Marathon Digital Holdings Schedules Conference Call for First Quarter 2024 Financial Results Earnings Webcast and Conference Call Set for Thursday, May 9, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, April 24, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:) ("Marathon" or "Company"), one of the world’s largest publicly traded Bitcoin miners and a leader in supporting and securing the Bitcoin ecosystem, will hold a webcast and conference call on Thursday, May 9, 2024 at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2024. Financial results will be published...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.